<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-24-46</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-24-6-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Demyelinating Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Vitamin D Status and Multiple Sclerosis Relapse</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>2010</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>01</month>
<year>2016</year>
</pub-date>
<volume>24</volume>
<issue>6</issue>
<fpage>46</fpage>
<lpage>47</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2010 The Author(s)</copyright-statement>
<copyright-year>2010</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1002/ana.21972" vol="67" page="618">
<article-title>Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Researchers at University of California, San Francisco, and State University of New York at Stony Brook, NY consecutively recruited patients with pediatric-onset multiple sclerosis into a prospective cohort to determine if vitamin D status is associated with the rate of subsequent clinical relapses.</p>
</abstract>
<kwd-group>
<kwd>Vitamin D Status</kwd>
<kwd>Hispanic Ethnicity</kwd>
<kwd>Pediatric-Onset Multiple Sclerosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Researchers at University of California, San Francisco, and State University of New York at Stony Brook, NY consecutively recruited patients with pediatric-onset multiple sclerosis into a prospective cohort to determine if vitamin D status is associated with the rate of subsequent clinical relapses. Among 110 patients followed, the mean serum 25-hydroxyvitamin D level was 22 +/- 9 ng/ml, and only 16 (15%) had normal unadjusted levels (&#x003E; 30 ng/ml). After adjustment for age, gender, race, ethnicity, disease duration, therapy, and length of follow-up, every 10 ng/ml increase in adjusted 25-hydroxyvitamin D level was associated with a 34% decrease in the rate of subsequent relapses (p=0.024). Only Hispanic ethnicity was independently associated with an increased risk of relapse. The finding suggests that supplementation of vitamin D stores may reduce risk of multiple sclerosis relapse and warrants investigation. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. Low vitamin D levels are associated with an increased relapse rate in pediatric-onset multiple sclerosis. Relapse rate in pediatric-onset is significantly higher than that in adult-onset cases [<xref ref-type="bibr" rid="CIT0002">2</xref>]. Mean age of the patients in the above study at time of blood collection was 15 years +/- SD3.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mowry</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Krupp</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Milazzo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chabas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Strober</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Belman</surname>
<given-names>AL</given-names>
</name>
<etal/>
</person-group>
<article-title>Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis</article-title>
<source>Ann Neurol</source>
<year>2010</year>
<month>May</month>
<volume>67</volume>
<issue>5</issue>
<fpage>618</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21972</pub-id>
<pub-id pub-id-type="pmid">20437559</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorman</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Polgar-Turcsanyi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chitnis</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis</article-title>
<source>Arch Neurol</source>
<year>2009</year>
<month>Jan</month>
<volume>66</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2008.505</pub-id>
<pub-id pub-id-type="pmid">19139299</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
